SCHEMBL28093149

SCHEMBL28093149

N#Cc1nccc2cccn12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLA P06280 2/20 0.38
LMNA P02545 1/20 0.38
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35
GAA P10253 2/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MAPT P10636 2/20 0.33
HCRTR1 O43613 1/20 0.33
RAB9A P51151 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ADORA3 P0DMS8 1/20 0.32
KDR P35968 1/20 0.32
CHEK1 O14757 1/20 0.32
LIMK1 P53667 1/20 0.32
MAPK14 Q16539 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
GRM5 P41594 1/20 0.31
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL398626 0.71 MAP2K2 (0.41) GLAALDH1A1KDM4EGAAHPGD
SCHEMBL14630027 0.71 ALDH1A1 (0.37) GLAALDH1A1KDM4EGAAHPGD
SCHEMBL1155337 0.71 KDM4E (0.37) GLAALDH1A1KDM4EGAAHPGD
SCHEMBL13138545 0.71 ADORA3 (0.38) GLAALDH1A1KDM4EGAAHPGD
SCHEMBL7072277 0.68 GLA (0.37) GLALMNAALDH1A1KDM4EGAA
SCHEMBL12603300 0.67 KDM4E (0.34) GLAALDH1A1KDM4EGAAHPGD
SCHEMBL27547856 0.67 ADORA3 (0.35) GLALMNAALDH1A1KDM4EGAA
SCHEMBL16376207 0.65 ADORA3 (0.50) GLAALDH1A1KDM4EGAAHPGD
SCHEMBL14629309 0.64 CHEK1 (0.39) GLALMNACHEK1
SCHEMBL2000282 0.63 ALOX15 (0.36) GLALMNAALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240246995-A1 PYRIMIDINONE DERIVATIVE AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USE Shanghai Simr Biotechnology Co., Ltd. (CN) 2024-07-25 US disclosed
EP-4324835-A1 PYRIMIDINONE DERIVATIVE AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USE Shanghai Simr Biotechnology Co., Ltd. (CN) 2024-02-21 EP disclosed
CN-105980386-A Pyrazolo compounds and uses thereof 基因泰克公司 2016-09-28 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240246995-A1 PYRIMIDINONE DERIVATIVE AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USE PLA2G1B, LYPLAL1, PLA2G12B GLA 1369/4885LMNA 330/4885ALDH1A1 812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.